Skip to Content

Join the 'Lymphangioleiomyomatosis' group to help and get support from people like you.

Lymphangioleiomyomatosis News

Related terms: LAM, Pulmonary Lymphangioleiomyomatosis

FDA Approves Rapamune (sirolimus) for Rare Lung Disease Lymphangioleiomyomatosis

Posted 1 Jun 2015 by Drugs.com

May 28, 2015 – The U.S. Food and Drug Administration today approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of childbearing age. This is the first drug approved to treat the disease. LAM is characterized by an abnormal growth of smooth muscle cells that invade lung tissues, including the airways, and ...

Ask a Question

Further Information

Related Condition Support Groups

Respiratory Tract Disease

Related Drug Support Groups

sirolimus, Rapamune